These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34233030)

  • 1. Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD.
    Vilarinho S; Ajmera V; Zheng M; Loomba R
    Hepatology; 2021 Oct; 74(4):2241-2250. PubMed ID: 34233030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign.
    Tobari M; Hashimoto E; Taniai M; Ikarashi Y; Kodama K; Kogiso T; Tokushige K; Takayoshi N; Hashimoto N
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1404-1410. PubMed ID: 30590868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lean non-alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross-sectional study.
    Khayyat YM
    Physiol Rep; 2021 Jul; 9(14):e14949. PubMed ID: 34278728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese population.
    Sheng G; Peng N; Hu C; Zhong L; Zhong M; Zou Y
    Lipids Health Dis; 2021 May; 20(1):50. PubMed ID: 33993872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
    Long MT; Noureddin M; Lim JK
    Gastroenterology; 2022 Sep; 163(3):764-774.e1. PubMed ID: 35842345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
    Chen N; Zhou J; Wang K; Li X; Li Z
    BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis.
    Lim JW; Dillon J; Miller M
    World J Gastroenterol; 2014 Jul; 20(26):8325-40. PubMed ID: 25024592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study.
    Sinn DH; Kang D; Cho SJ; Paik SW; Guallar E; Cho J; Gwak GY
    Eur J Endocrinol; 2019 Aug; 181(2):185-192. PubMed ID: 31176297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of non-alcoholic fatty liver disease in non-obese and lean individuals.
    Ahadi M; Molooghi K; Masoudifar N; Namdar AB; Vossoughinia H; Farzanehfar M
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1497-1507. PubMed ID: 33217052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Lu FB; Zheng KI; Rios RS; Targher G; Byrne CD; Zheng MH
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2041-2050. PubMed ID: 32573017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka.
    Niriella MA; Kasturiratne A; Pathmeswaran A; De Silva ST; Perera KR; Subasinghe SKCE; Kodisinghe SK; Piyaratna TACL; Vithiya K; Dassanayaka AS; De Silva AP; Wickramasinghe AR; Takeuchi F; Kato N; de Silva HJ
    Hepatol Int; 2019 May; 13(3):314-322. PubMed ID: 30539516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort study.
    Wei L; Cheng X; Luo Y; Yang R; Lei Z; Jiang H; Chen L
    Diabetes Metab; 2021 May; 47(3):101200. PubMed ID: 33075504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Lean Adolescents in the United States.
    Conjeevaram Selvakumar PK; Kabbany MN; Lopez R; Rayas MS; Lynch JL; Alkhouri N
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):75-79. PubMed ID: 29570139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals?
    Sookoian S; Pirola CJ
    Gastroenterology; 2016 Jun; 150(8):1698-1703.e2. PubMed ID: 26775630
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity.
    Sinha N; Mukhopadhyay S; Sau M
    Indian J Gastroenterol; 2020 Feb; 39(1):75-83. PubMed ID: 32314167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lean non-alcoholic fatty liver disease.
    Wang AY; Dhaliwal J; Mouzaki M
    Clin Nutr; 2019 Jun; 38(3):975-981. PubMed ID: 30466956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease.
    Perakakis N; Stefanakis K; Mantzoros CS
    Metabolism; 2020 Oct; 111S():154320. PubMed ID: 32712221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
    Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
    World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.